- Home
- CRBG vs QGEN Comparison
CRBG vs QGEN Comparison
Compare CRBG & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRBG | QGEN |
|---|---|---|
| Founded | 1957 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 10.2B |
| IPO Year | 2022 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CRBG | QGEN |
|---|---|---|
| Price | $28.27 | $37.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | $35.15 | ★ $45.76 |
| AVG Volume (30 Days) | ★ 4.9M | 2.1M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | 3.56% | ★ 7.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,481,000,000.00 | N/A |
| Revenue This Year | $16.24 | $8.18 |
| Revenue Next Year | $5.65 | $5.71 |
| P/E Ratio | ★ N/A | $24.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.19 | $32.53 |
| 52 Week High | $36.57 | $57.82 |
Technical Indicators
Market Signals| Indicator | CRBG | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.10 | 56.42 |
| Support Level | $27.29 | $32.85 |
| Resistance Level | $28.25 | $38.10 |
| Average True Range (ATR) | 0.84 | 0.88 |
| MACD | 0.06 | 0.33 |
| Stochastic Oscillator | 98.83 | 79.14 |
Price Performance
Historical ComparisonAbout CRBG Corebridge Financial Inc.
Corebridge Financial Inc provides retirement solutions and insurance products in the United States, offering fixed, fixed index, and registered index-linked annuities with optional benefits, including lifetime income guarantees and death benefits, distributed through an extensive platform. The company operates through the Individual Retirement, Group Retirement, Life Insurance, Institutional Markets, and Corporate and Other segments. Individual Retirement consists of fixed, fixed index, and registered index-linked annuities, while Group Retirement includes recordkeeping and plan administrative services. The company operates in North America and internationally, with overall revenue coming from North America.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).